Kirsty is a rapid-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Kirsty will be available as a single-patient-use prefilled pen for.
Use KIRSTY in accordance with the insulin pump system’s instructions for use. Train patients using continuous subcutaneous insulin fusion pump therapy to administer insulin by injection and have.
Aug 19, 2025 · Kirsty for injection: 100 units/mL (U-100) is a clear and colorless solution available as a 10 mL multiple-dose vial and a 3 mL single-patient-use prefilled pen. The safety and effectiveness of.
Kirsty or Kirstie is a feminine given name and nickname. [1][2] It is a Scottish diminutive of Christine in English-speaking countries and is also linked to Kirsten — the Scandinavian version of Christine.
Learn about Kirsty (insulin aspart) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
Jul 17, 2025 · The FDA has approved Kirsty (insulin aspart-xjhz), an interchangeable biosimilar to Novolog, to improve glycemic control in diabetes mellitus.
Jul 15, 2025 · The FDA has approved Kirsty, the first interchangeable insulin aspart biosimilar, enhancing access to affordable diabetes care for millions.
Never share a KIRSTY prefilled pen, needles or syringes between patients, even if the needle is changed.
Jul 15, 2025 · KIRSTY is a rapid-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. KIRSTY will be available as a single-patient-use.
